Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mirum Pharmaceuticals Inc MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development and commercialization of therapies for debilitating rare and orphan diseases. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal (chenodiol) tablets. Livmarli is an orally administered, minimally... see more

NDAQ:MIRM - Post Discussion

Mirum Pharmaceuticals Inc > MIRM Price Target Alert: $66.00. Issued by H.C. Wainwright
View:
Post by whytestocks on Jun 17, 2024 1:15pm

MIRM Price Target Alert: $66.00. Issued by H.C. Wainwright

Breaking News: $MIRM MIRM Price Target Alert: $66.00. Issued by H.C. Wainwright2024-06-17 13:00:06 ET Ed Arce from H.C. Wainwright issued a price target of $66.00 for MIRM on 2024-06-17 11:32:00. The adjusted price target was set to $66.00. At the time of the announcement, MIRM was trading at $30.99. The overall price target consensus is at $50.67 ...MIRM - MIRM Price Target Alert: $66.00. Issued by H.C. Wainwright
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities